Trial · NCT01607203
Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist
NCT01607203, Phase 4, Completed, AZ Jan Palfijn Gent; results first posted 2015-02-19
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist. Trials, record NCT01607203. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01607203
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist
- NCT number
- NCT01607203
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 120 participants, actual
- Lead sponsor
- AZ Jan Palfijn Gent
- Conditions
- Infertility
- Interventions
- Decapeptyl Daily, pregnyl
- First posted
- 2012-05-30
- Last updated
- 2015-02-19
- Results first posted
- 2015-02-19
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | MII Oocytes | 3 weeks | the number of mature oocytes retrieved |
| Secondary | Pregnancy Rate | 12 weeks | the number of pregnancies obtained, wich still is the most important issue for the patients |
| Secondary | Patients With Cryopreserved Embryos | 4 weeks |
Source ClinicalTrials.gov
Outcomes3
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | MII Oocytes | 3 weeks | cumulus oocyte complex | MEAN | |
| SECONDARY | Pregnancy Rate | 12 weeks | pregnancies | NUMBER | |
| SECONDARY | Patients With Cryopreserved Embryos | 4 weeks | patients with cryopreserved embryos | NUMBER |
Source ClinicalTrials.gov
Results by group6
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| MII Oocytes | hCG TRIGGERING | 9.2 | Standard Deviation 6.7 | cumulus oocyte complex | |
| MII Oocytes | hCG and GnRH Agonist Triggering | 10.3 | Standard Deviation 6.8 | cumulus oocyte complex | |
| Pregnancy Rate | hCG Triggering | 28 | pregnancies | ||
| Pregnancy Rate | hCG and GnRH Agonist Triggering | 45 | pregnancies | ||
| Patients With Cryopreserved Embryos | hCG Triggering | 21 | patients with cryopreserved embryos | ||
| Patients With Cryopreserved Embryos | hCG and GnRH Agonist Triggering | 33 | patients with cryopreserved embryos |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | hCG Triggering | 59 | |
| Overall Study | STARTED | hCG and GnRH Agonist Triggering | 61 | |
| Overall Study | COMPLETED | hCG Triggering | 59 | |
| Overall Study | COMPLETED | hCG and GnRH Agonist Triggering | 61 | |
| Overall Study | NOT COMPLETED | hCG Triggering | 0 | |
| Overall Study | NOT COMPLETED | hCG and GnRH Agonist Triggering | 0 |
Source ClinicalTrials.gov
Adverse events2
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | OHSS | Metabolism and nutrition disorders | hCG TRIGGERING | 0 | 59 | 0 |
| other | OHSS | Metabolism and nutrition disorders | hCG and GnRH Agonist Triggering | 0 | 61 | 0 |
Source ClinicalTrials.gov
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | hCG TRIGGERING | ||
| Total, all-cause mortality | hCG and GnRH Agonist Triggering | ||
| Total, other adverse events | hCG TRIGGERING | 0 | 59 |
| Total, other adverse events | hCG and GnRH Agonist Triggering | 0 | 61 |
| Total, serious adverse events | hCG TRIGGERING | 0 | 59 |
| Total, serious adverse events | hCG and GnRH Agonist Triggering | 0 | 61 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| hCG TRIGGERING vs hCG and GnRH Agonist Triggering: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01607203
GET https://conductscience.org/api/trials/v1/NCT01607203/registered